Lancemaside A from Codonopsis lanceolata prevents hypertension by inhibiting NADPH oxidase 2-mediated MAPK signalling and improving NO bioavailability in rats
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, You Kyoung | - |
dc.contributor.author | Han, A. Young | - |
dc.contributor.author | Hsieh, Yu Shan | - |
dc.contributor.author | Kwon, Soonho | - |
dc.contributor.author | Kim, Jinhye | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.contributor.author | Seol, Geun Hee | - |
dc.date.accessioned | 2021-09-01T08:23:44Z | - |
dc.date.available | 2021-09-01T08:23:44Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-09 | - |
dc.identifier.issn | 0022-3573 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/63444 | - |
dc.description.abstract | Objectives This study investigated whether lancemaside A (LMA) can prevent hypertension and assessed the mechanisms of action of LMA in rats. Methods Hypertension was induced by chronic immobilization stress and nicotine administration. Hypertensive vehicle rats were treated with LMA (1, 20, or 40 mg/kg) or nifedipine (10 mg/kg) as a positive control daily for 3 weeks. Key findings In hypertensive vehicle rats, LMA dose-dependently reduced systolic blood pressure. LMA doses of 20 and 40 mg/kg reduced the aortic expression of nicotinamide adenine dinucleotide phosphate oxidase (NOX)2 (both P < 0.01), and 40 mg/kg LMA reduced serum malondialdehyde (P < 0.01). Serum nitrite levels were significantly higher in LMA treated rats than in hypertensive vehicle rats, with LMA doses of 20 and 40 mg/kg reducing the expression of endothelial nitric oxide synthase in rat aortas (P P < 0.01, respectively). LMA also reduced the aortic levels of nuclear factor kappa B and the activation of the three isoforms of mitogen-activated protein kinase (MAPK). Conclusions Lancemaside A prevents hypertension in rats by inhibiting the activation of MAPK signalling and the impairment in nitric oxide bioavailability due to NOX2-mediated oxidative stress. Thus, LMA may act as a preventive agent for hypertension. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.subject | REDUCES BLOOD-PRESSURE | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | NITRIC-OXIDE | - |
dc.subject | ENDOTHELIAL DYSFUNCTION | - |
dc.subject | INDUCED INFLAMMATION | - |
dc.subject | SYNTHASE EXPRESSION | - |
dc.subject | KINASE PATHWAYS | - |
dc.subject | UP-REGULATION | - |
dc.subject | CELLS | - |
dc.subject | MODULATION | - |
dc.title | Lancemaside A from Codonopsis lanceolata prevents hypertension by inhibiting NADPH oxidase 2-mediated MAPK signalling and improving NO bioavailability in rats | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, A. Young | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.contributor.affiliatedAuthor | Seol, Geun Hee | - |
dc.identifier.doi | 10.1111/jphp.13140 | - |
dc.identifier.scopusid | 2-s2.0-85070347093 | - |
dc.identifier.wosid | 000478595000012 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PHARMACY AND PHARMACOLOGY, v.71, no.9, pp.1458 - 1468 | - |
dc.relation.isPartOf | JOURNAL OF PHARMACY AND PHARMACOLOGY | - |
dc.citation.title | JOURNAL OF PHARMACY AND PHARMACOLOGY | - |
dc.citation.volume | 71 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 1458 | - |
dc.citation.endPage | 1468 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | REDUCES BLOOD-PRESSURE | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | ENDOTHELIAL DYSFUNCTION | - |
dc.subject.keywordPlus | INDUCED INFLAMMATION | - |
dc.subject.keywordPlus | SYNTHASE EXPRESSION | - |
dc.subject.keywordPlus | KINASE PATHWAYS | - |
dc.subject.keywordPlus | UP-REGULATION | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | MODULATION | - |
dc.subject.keywordAuthor | antihypertension | - |
dc.subject.keywordAuthor | lancemaside A | - |
dc.subject.keywordAuthor | MAPK | - |
dc.subject.keywordAuthor | NADPH oxidase | - |
dc.subject.keywordAuthor | NO bioavailability | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.